Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials
Starting this October, scientists at Imperial College London’s (ICL) Centre for Psychedelic Research will assess psilocybin-assisted therapy for gambling addiction in a government-funded study focused on understanding brain function in the disorder through changes in the reward system.
Also in October, the University of Calgary will launch a clinical trial combining a single dose of psilocybin -either 1mg or 25mg- paired with five sessions of Motivational Enhancement Therapy (MET) toward reducing heavy drinking in 128 patients with Alcohol Use Disorder (AUD.)
Last, Jan. 2024 would be the start date of a Phase 2 mixed-methods clinical trial assessing the feasibility, safety and preliminary efficacy of one psilocybin dose to alleviate opioid-refractory pain in 15 patients with advanced cancer. Read more HERE.
From Ice Rink To Healing Haven: Former NHL Player Sets Up Psilocybin Therapy Center In Colorado
As professional athletes continue to endorse psychedelic-assisted therapy, former Colorado Avalanche defenseman Kyle Quincey is taking it to the next level. He recently announced the building of a psilocybin-assisted therapy center in the state where voters approved the treatment last November. Read more HERE.
Federico Fellini's LSD Journey: How It Inspired Some Of The Greatest Films Of All Time
A newly published analysis of Federico Fellini's films explores how LSD therapy would have fueled the famed Italian filmmaker’s creative process regarding time, space, body and perception of the self. Read more HERE.
Canada Vs. US: Surveys Reveal How People Use Psychedelics, Relationships With Healthcare Providers
Published this July and funded by partners SABI Mind, …